Vitrolife

Excellence in reproductive health Today, we support customers worldwide - always with sustainability in mind. We are your committed partner for the IVF journey.

Vitrolife is committed to supporting successful treatment outcomes and has been dedicated to IVF since 1994, when the field was still young. In 2021, Vitrolife acquired Igenomix, a leader in reproductive genetic testing services for fertility clinics, founded in 2011. Together we create Vitrolife Group, a global leader in reproductive health. By combining Igenomix’s portfolio of reproductive genet

ic testing services with Vitrolife’s best-in-class IVF device portfolio, we support clinics and patients across the fertility journey. Based on science and advanced research capabilities, our aim is to deliver products and services for the entire fertility journey, providing consistent performance and guaranteed quality. We are a sustainable market leader and aim to be the preferred partner to the fertility clinics by providing superior products and services. Currently, Vitrolife Group are approximately 1,100 people worldwide headquartered in Gothenburg, Sweden. Our products and services are available in more than 110 countries, through our own presence in 32 countries, and a network of distributors. Our vision is to enable people to fulfil the dream of having a healthy baby), and we achieve this by supporting our customers in delivering successful treatment outcomes. Our mission is to be the leading global partner in reproductive health, striving for better treatment outcomes for patients. Together we create excellence in reproductive health. We can help you maximise success. – Together. All the way. The Vitrolife AB (publ) share is listed on Nasdaq Stockholm.

04/06/2026

💡Reducing subjectivity in embryo selection through AI-assisted assessment

In our recent article, inspired by findings from a new clinical publication, Mitchell Rosen, MD, shares perspectives on how AI-assisted embryo assessment may help reduce subjectivity in embryo selection, support clinical decision-making, and provide added value in complex cases and embryologist training.

The article also explores how technologies such as iDAScore® may help minimise variability and support a more standardised approach to embryo evaluation across IVF laboratories.

Read the article here:
👉 https://ow.ly/g6xU50Z5ycB

03/06/2026

We are excited to present Part 1 of the mini-series: How Terra Fertility is elevating care and supporting outcomes with EmbryoScope and PGT-A Plus.

Read the full blog post to learn key clinical (and workflow) advantages of both EmbryoScope and PGT-A Plus compared to current standard of care.

💡How does your practice evaluate new technologies for implementation? What criteria is most important?

👉https://ow.ly/Se6M50Z6YN8

01/06/2026

Quality all the way 💡

At Vitrolife Group, we all work to achieve the same goal, whatever our role – to help people fulfil the dream of having a healthy baby. To do this, we aim to deliver the best products for the entire IVF journey that have consistent performance and guaranteed quality.

To provide an unbroken chain of innovative high-quality products we focus on quality from initial research and development to production, distribution and clinical and scientific support.

Read more about our four cornerstones of our quality processes here: 👉 https://ow.ly/xyOX50Wvamj

29/05/2026

💡Why does consistency in embryo assessment matter?

In our recent article, inspired by a new clinical publication, Mark Larman, VP Medical Affairs at Vitrolife Group North America, highlights the importance of standardisation in embryo assessment and how AI-assisted decision-support tools such as iDAScore®, may help reduce variability between embryologists, support laboratory performance, and contribute to improved clinical outcomes.

Read the article here: https://ow.ly/p7jc50Z5st7

21/05/2026

💡Quality all the way

Behind every safe and reliable product is a commitment to doing more than what’s expected. With our beyond-industry standard MEA and strict quality control processes, we build confidence through science, precision and a constant dedication to safety.

Explore our industry-leading MEA and cell-count here:
https://ow.ly/P8ip50Z2Crm

20/05/2026

We're excited to announce that we will be participating in the 42nd Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) in London.

Join us at booth C07 during the congress - we look forward to connecting with you and sharing knowledge. More details about our presence and activities at ESHRE 2026 will be announced soon, so stay tuned for updates.

14/05/2026

At Vitrolife Group, quality is not just a standard - it’s a value that guides everything we do.

In this video, Erik Strait, MEA Laboratory Manager at Vitrolife Group, shares his perspective on the vital role quality plays in every part of our work - from research and development to manufacturing and delivery.

Read more about how we ensure quality throughout our production process here:
👉 https://www.vitrolife.com/why-vitrolife/quality-that-matters/quality-control/?utm_source=Facebook&utm_medium=Social%20Media&utm_campaign=Quality

13/05/2026

💡How can AI-assisted assessment support greater consistency in embryo evaluation?

In this latest article, inspired by findings from a new clinical publication, embryologists, laboratory leaders and medical experts share their perspectives on how iDAScore® is being used to help reduce variability, support embryologist decision-making, and bring greater standardisation to IVF laboratory workflows.

Explore the expert testimonials and discover how clinics are integrating AI-powered assessment into everyday practice. Click on the link to read the article:

https://ow.ly/B12b50YYSV7

08/05/2026

ASPIRE 2026 - Beijing, China!

It has been a fantastic start at the Vitrolife Group booth B72, filled with inspiring conversations, exciting academic sessions, live product demonstrations, and valuable connections with colleagues and partners from across the fertility community.

We are proud to showcase our comprehensive IVF workflow solutions designed to support every step of the fertility journey - and even more excited to exchange insights and experiences with so many passionate professionals.

We can’t wait to continue the journey tomorrow!

07/05/2026

💡Always available to meet customer demand, flexible and trusted with 52 weeks of supply, delivering top quality, MEA-tested products.

As part of our continued growth, we are expanding into a sustainable, state-of-the-art media manufacturing facility that meets the highest standards for quality, safety, and efficiency.

This site will combine innovative technology with tailor-made reliability and play a vital role in supporting people in fulfilling their dream of having a healthy baby.

Adress

Gustaf Werners Gata 2
Västra Frölunda
42132

Webbplats

https://www.vitrolife.com/

Aviseringar

Var den första att veta och låt oss skicka ett mail när Vitrolife postar nyheter och kampanjer. Din e-postadress kommer inte att användas för något annat ändamål, och du kan när som helst avbryta prenumerationen.

Vill du placera din affär längst upp i Utrustningföretag-listan i Västra Frölunda?

Dela

Typ

Leverantör av medicinsk utrustning